Laryngeal Adaptation for Speech and Swallowing

Sponsor
University of Florida (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03770377
Collaborator
National Institute on Deafness and Other Communication Disorders (NIDCD) (NIH), National Institutes of Health (NIH) (NIH)
0
5
12.2

Study Details

Study Description

Brief Summary

This study will test laryngeal adaptation in speech and swallowing function in healthy adults, in patients with cerebral stroke, and in patients with spinocerebellar ataxia type 6. The findings from this proposal will be the first step toward implementing rehabilitation techniques that help patients to prevent speech and swallowing errors before they occur.

Condition or Disease Intervention/Treatment Phase
  • Device: Intermittent Perturbation to Continuous Perturbation
  • Device: Continuous Perturbation to Intermittent Perturbation
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
A cross-sectional study design will be used to examine laryngeal adaptation across all study groups.A cross-sectional study design will be used to examine laryngeal adaptation across all study groups.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Laryngeal Adaptation for Speech and Swallowing
Actual Study Start Date :
Aug 24, 2018
Actual Primary Completion Date :
Aug 30, 2019
Actual Study Completion Date :
Aug 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Stroke without Dysarthria

Examine laryngeal adaptation across all study groups: (1) baseline measures of speech or swallowing , (2) a clinical examination of disease/condition severity and (3) the experimental paradigm.

Device: Intermittent Perturbation to Continuous Perturbation
Manipulate the Movement Planning Period (MPP), by interrupting sensory predictions by removing e-stim during the inter-trial interval (Intermittent Perturbation), followed by a washout/de-adaptation period.
Other Names:
  • I to C Paradigm
  • Device: Continuous Perturbation to Intermittent Perturbation
    Manipulate the Movement Planning Period (MPP), by keep sensory input about the perturbation constant by maintaining e-stim during the inter-trial interval.
    Other Names:
  • C to I Paradigm
  • Experimental: Stroke with Dysarthria

    Examine laryngeal adaptation across all study groups: (1) baseline measures of speech or swallowing , (2) a clinical examination of disease/condition severity and (3) the experimental paradigm.

    Device: Intermittent Perturbation to Continuous Perturbation
    Manipulate the Movement Planning Period (MPP), by interrupting sensory predictions by removing e-stim during the inter-trial interval (Intermittent Perturbation), followed by a washout/de-adaptation period.
    Other Names:
  • I to C Paradigm
  • Device: Continuous Perturbation to Intermittent Perturbation
    Manipulate the Movement Planning Period (MPP), by keep sensory input about the perturbation constant by maintaining e-stim during the inter-trial interval.
    Other Names:
  • C to I Paradigm
  • Experimental: SCA6 without Dysarthria

    Examine laryngeal adaptation across all study groups: (1) baseline measures of speech or swallowing , (2) a clinical examination of disease/condition severity and (3) the experimental paradigm.

    Device: Intermittent Perturbation to Continuous Perturbation
    Manipulate the Movement Planning Period (MPP), by interrupting sensory predictions by removing e-stim during the inter-trial interval (Intermittent Perturbation), followed by a washout/de-adaptation period.
    Other Names:
  • I to C Paradigm
  • Device: Continuous Perturbation to Intermittent Perturbation
    Manipulate the Movement Planning Period (MPP), by keep sensory input about the perturbation constant by maintaining e-stim during the inter-trial interval.
    Other Names:
  • C to I Paradigm
  • Experimental: SCA6 with Dysarthria

    Examine laryngeal adaptation across all study groups: (1) baseline measures of speech or swallowing , (2) a clinical examination of disease/condition severity and (3) the experimental paradigm.

    Device: Intermittent Perturbation to Continuous Perturbation
    Manipulate the Movement Planning Period (MPP), by interrupting sensory predictions by removing e-stim during the inter-trial interval (Intermittent Perturbation), followed by a washout/de-adaptation period.
    Other Names:
  • I to C Paradigm
  • Device: Continuous Perturbation to Intermittent Perturbation
    Manipulate the Movement Planning Period (MPP), by keep sensory input about the perturbation constant by maintaining e-stim during the inter-trial interval.
    Other Names:
  • C to I Paradigm
  • Active Comparator: Age-Matched Controls

    Examine laryngeal adaptation across all study groups: (1) baseline measures of speech or swallowing , (2) a clinical examination of disease/condition severity and (3) the experimental paradigm.

    Device: Intermittent Perturbation to Continuous Perturbation
    Manipulate the Movement Planning Period (MPP), by interrupting sensory predictions by removing e-stim during the inter-trial interval (Intermittent Perturbation), followed by a washout/de-adaptation period.
    Other Names:
  • I to C Paradigm
  • Device: Continuous Perturbation to Intermittent Perturbation
    Manipulate the Movement Planning Period (MPP), by keep sensory input about the perturbation constant by maintaining e-stim during the inter-trial interval.
    Other Names:
  • C to I Paradigm
  • Outcome Measures

    Primary Outcome Measures

    1. Laryngeal Adaptation in Speech [Day 1]

      To differentiate laryngeal adaptation during speech among cerebral stroke, SCA6, and healthy controls when vocal loudness is perturbed with expiratory loading.

    2. Laryngeal Adaptation in Swallowing [Day 1]

      To differentiate laryngeal adaptation among cerebral stroke, SCA6, and healthy controls when swallowing is perturbed with neck surface electrical stimulation to restrict laryngeal elevation.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    21 Years to 100 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Patient Inclusion Criteria:

    All stroke and ataxia

    Ataxia

    • DNA diagnosis of SCA6 and phenotype consistent with the DNA diagnosis

    • No recessive, X-linked or mitochondrial

    Stroke

    • Bilateral or unilateral middle cerebral artery (MCA) stroke

    • No structural abnormalities (i.e. nodules)

    • Dysphagia involving laryngeal dysfunction

    Stroke and ataxia with speech and swallowing disorders

    • no structural abnormalities

    • dysphagia involving laryngeal dysfunction

    Patient Exclusion Criteria:
    • Montreal Cognitive Assess. <24

    • Moderate to severe hearing loss

    • Barium allergy

    • Other confounding speech disorder (i.e. stuttering)

    • Chemo-radiation, surgical head and neck treatment

    • Smoking Hx in the past 5 yrs or >5 years at any one time

    • Twenty one years of age or older

    • Breathing disorders or diseases

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • University of Florida
    • National Institute on Deafness and Other Communication Disorders (NIDCD)
    • National Institutes of Health (NIH)

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Florida
    ClinicalTrials.gov Identifier:
    NCT03770377
    Other Study ID Numbers:
    • IRB201702917 -A
    • R01DC016275-01A1
    • OCR19032
    • 5R01DC016275-02
    First Posted:
    Dec 10, 2018
    Last Update Posted:
    Jun 15, 2021
    Last Verified:
    Jun 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    Yes
    Keywords provided by University of Florida
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 15, 2021